Pulmonary hypertension
Conditions
Interventions
Sponsors
The Southern Yunnan Central Hospital of Yunnan(The First People's Hospital of Honghe)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Inclusion criteria (experimental group): ? meet the category 3 of PAH classification revised by the sixth world pulmonary hypertension conference in 2018, have chronic obstructive pulmonary disease complicated with PAH, and have a long-term residence history in the province; ? The patient's medical records are complete; ? Informed consent of patients and their families. (2) Inclusion criteria (control group 1): ? patients with long-term residence history and chronic obstructive pulmonary disease without PAH; ? The patient's medical records are complete; ? Informed consent of patients and their families. (3) Inclusion criteria (control group 2): ? patients with long-term residence history and no chronic obstructive pulmonary disease and PAH; ? The patient's medical records are complete; ? Informed consent of patients and their families
Exclusion criteria
Exclusion criteria: (1) Exclusion criteria (experimental group): ? non resident population in the province with PAH caused by idiopathic PAH, left heart disease, congenital heart disease, drugs, portal hypertension, HIV infection and other reasons; ? Patients with liver and renal insufficiency; ? Patients with thyroid, tumor and bone marrow hyperplasia; ? Patients with recent acute pulmonary embolism; ? Preoperative MMSE score < 23, with cognitive impairment. (2) Exclusion criteria (control group 1): ? non resident population in the province with PAH caused by idiopathic PAH, left heart disease, congenital heart disease, drugs, portal hypertension, HIV infection and other reasons; ? Patients with liver and renal insufficiency; ? Patients with thyroid, tumor and bone marrow hyperplasia; ? Patients with recent acute pulmonary embolism; ? Preoperative MMSE score < 23, with cognitive impairment. (3) Exclusion criteria (control group 2): ? non resident population in the province with PAH caused by idiopathic PAH, left heart disease, congenital heart disease, drugs, portal hypertension, HIV infection and other reasons; ? Patients with liver and renal insufficiency; ? Patients with thyroid, tumor and bone marrow hyperplasia; ? Patients with recent acute pulmonary embolism; ? Preoperative MMSE score < 23, with cognitive impairment.
Countries
China
Contacts
Public ContactWang Sibo
The Southern Yunnan Central Hospital of Yunnan/The First People's Hospital of Honghe
Outcome results
None listed